Rutherford Health Plc.

Rutherford Health is at the vanguard of advancing cancer care, with a network of oncology centres across the UK (the Rutherford Cancer Centres) offering a comprehensive range of cancer treatments to patients, including proton beam therapy. The Rutherford Cancer Centres offer proton beam therapy, along with radiotherapy, chemotherapy, immunotherapy, diagnostic imaging and supportive care services. Treatment at the centres is available to medically-insured private patients, self-paying patients and patients referred by the NHS (where commissioned to do so). The first centre in Newport, South Wales, was the first in the UK to offer and treat a patient in the UK with high energy proton beam therapy in 2018. As well as the Rutherford Cancer Centre South Wales, we have opened two further centres in 2019 – the Rutherford Cancer Centre North East in Northumberland and the Rutherford Cancer Centre Thames Valley in Reading, with proton therapy now available in both. A fourth site is under construction in Liverpool, the Rutherford Cancer Centre North West and is due to open in 2020. Rutherford Health plc has partnered with world-leading healthcare technology providers to equip each centre with the very latest and innovative technology, including IBA, Philips and Elekta. Our aim is to improve access to radiotherapy and specifically precision radiotherapy, by providing the majority of patients in the UK with a state-of-the-art cancer centre within a ninety-minute journey of their front door, wherever they are in the UK.